• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $GRDX

    GridAI Technologies Corp.

    Subscribe to $GRDX
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2016

    Exchange: NASDAQ

    Recent Analyst Ratings for GridAI Technologies Corp.

    DatePrice TargetRatingAnalyst
    See more ratings

    GridAI Technologies Corp. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Powell Max Limited Successfully Repositions for Its Next Phase of Growth

    Hong Kong, TX, March 09, 2026 (GLOBE NEWSWIRE) -- Powell Max Limited (NASDAQ:PMAX) ("Powell Max" or the "Company"), a financial communications services provider, is pleased to provide the following corporate update regarding its successful repositioning. Key Highlights: Raised $17 million in capital from new investorsAppointed new Chairman and Chief Executive Officer Geordan PursgloveReconstituted the Board of DirectorsRegained compliance with Nasdaq listing requirements Powell Max Chairman and Chief Executive Officer Geordan Pursglove commented, "My first month at Powell Max has been extremely productive. We successfully completed a corporate restructuring in a short timeframe, raised

    3/9/26 8:30:00 AM ET
    $ALBT
    $CISO
    $GRDX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Professional Services
    Consumer Discretionary

    IBN Announces Latest Episode of The TechMediaWire Podcast featuring Marshall Chapin, CEO of Grid AI Corp.

    AUSTIN, Texas, March 05, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The TechMediaWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The TechMediaWire Podcast delivers informative updates and exclusive interviews with executives operating in the tech industry. The TechMediaWire Podcast's latest episode features Marshall Chapin, CEO of Grid AI Corp., wholly-owned by GridAI Technologies Corp. (NASDAQ:GRDX), a technology company focused on intelligent en

    3/5/26 8:00:00 AM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GridAI Technologies Corp. Appoints Veteran Energy Executive Tim Healy as Executive Chairman of Grid AI Corp.

    BOCA RATON, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- via IBN – GridAI Technologies Corp. (NASDAQ:GRDX), a technology company focused on intelligent energy orchestration for hyperscale AI data centers, today announced the appointment of Tim Healy as Executive Chairman of the Board of Grid AI Corp., the Company's wholly owned operating subsidiary. Healy brings more than two decades of experience as a founder, CEO, board leader, and investor across the energy technology and energy transition landscape. Over his career, he has founded multiple public companies, establishing a track record of scaling innovative platforms from early commercialization through global deployment and strategic exits

    2/4/26 8:00:00 AM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IBN Initiates Coverage of GridAI Technologies Corp.

    AUSTIN, Texas, Jan. 26, 2026 (GLOBE NEWSWIRE) -- via IBN – GridAI Technologies Corp. (NASDAQ:GRDX), a company operating at the intersection of artificial intelligence and energy infrastructure, has engaged IBN, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy. Following its acquisition of Grid AI Corp., GridAI Technologies is focused on enabling more flexible, resilient, and economically optimized electricity systems by coordinating generation, storage, and demand in real time through software-driven control. The company's approach integrates with existing energy hardware, allowing large power us

    1/26/26 8:30:00 AM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GridAI Technologies Corp. SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by GridAI Technologies Corp.

    SCHEDULE 13G/A - GridAI Technologies Corp. (0001604191) (Subject)

    2/12/26 2:14:12 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GridAI Technologies Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

    8-K - GridAI Technologies Corp. (0001604191) (Filer)

    1/7/26 4:05:41 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GridAI Technologies Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - GridAI Technologies Corp. (0001604191) (Filer)

    12/23/25 4:10:54 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GridAI Technologies Corp. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Borkowski Edward was granted 40,000 shares, increasing direct ownership by 198% to 60,248 units (SEC Form 4)

    4 - GridAI Technologies Corp. (0001604191) (Issuer)

    1/8/26 5:28:29 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Uppal Manpreet was granted 40,000 shares (SEC Form 4)

    4 - GridAI Technologies Corp. (0001604191) (Issuer)

    1/5/26 5:24:51 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Pursglove Geordan Garrett was granted 40,000 shares (SEC Form 4)

    4 - GridAI Technologies Corp. (0001604191) (Issuer)

    1/5/26 4:57:27 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Sawyer Jason David was granted 40,000 shares (SEC Form 4)

    4 - GridAI Technologies Corp. (0001604191) (Issuer)

    12/29/25 5:59:24 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Interim CFO Skowron Anna was granted 65,000 shares (SEC Form 4)

    4 - GridAI Technologies Corp. (0001604191) (Issuer)

    12/29/25 5:32:12 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Skowron Anna

    3 - GridAI Technologies Corp. (0001604191) (Issuer)

    12/29/25 5:31:37 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GridAI Technologies Corp. Leadership Updates

    Live Leadership Updates

    View All

    GridAI Technologies Corp. Appoints Veteran Energy Executive Tim Healy as Executive Chairman of Grid AI Corp.

    BOCA RATON, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- via IBN – GridAI Technologies Corp. (NASDAQ:GRDX), a technology company focused on intelligent energy orchestration for hyperscale AI data centers, today announced the appointment of Tim Healy as Executive Chairman of the Board of Grid AI Corp., the Company's wholly owned operating subsidiary. Healy brings more than two decades of experience as a founder, CEO, board leader, and investor across the energy technology and energy transition landscape. Over his career, he has founded multiple public companies, establishing a track record of scaling innovative platforms from early commercialization through global deployment and strategic exits

    2/4/26 8:00:00 AM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care